+1 858-523-8231
Login | Register
menu
AA Blocks, Building Blocks, Catalysts, Inhibitors
Login | Register
27291-96-9,MFCD11106178
Catalog No.:AA00JWBX

27291-96-9 | benzene-1,2-disulfonamide

Pack Size
Purity
Availability
Price(USD)
Quantity
  
1g
95+%
2 weeks  
$2,052.00   $1,436.00
- +
2g
95+%
2 weeks  
$3,062.00   $2,143.00
- +
5g
95+%
2 weeks  
$4,476.00   $3,133.00
- +
10g
95+%
2 weeks  
$6,533.00   $4,573.00
- +
25g
95+%
2 weeks  
$9,729.00   $6,810.00
- +
50g
95+%
2 weeks  
$14,394.00   $10,076.00
- +
100g
95+%
2 weeks  
$20,419.00   $14,293.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
Technical Information
Catalog Number:
AA00JWBX
Chemical Name:
benzene-1,2-disulfonamide
CAS Number:
27291-96-9
Molecular Formula:
C6H8N2O4S2
Molecular Weight:
236.2687
MDL Number:
MFCD11106178
SMILES:
NS(=O)(=O)c1ccccc1S(=O)(=O)N
Properties
Computed Properties
 
Complexity:
349  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0  
Defined Bond Stereocenter Count:
0  
Formal Charge:
0  
Heavy Atom Count:
14  
Hydrogen Bond Acceptor Count:
6  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0  
Rotatable Bond Count:
2  
Undefined Atom Stereocenter Count:
0  
Undefined Bond Stereocenter Count:
0  
XLogP3:
-1.3  

Downstream Synthesis Route

[1]CurrentPatentAssignee:ASTRAZENECAPLC-US2009/131468,2009,A1Locationinpatent:Page/Pagecolumn27;48-49

[2]CurrentPatentAssignee:ASTRAZENECAPLC-WO2009/64251,2009,A1Locationinpatent:Page/Pagecolumn42

[1]CurrentPatentAssignee:ASTRAZENECAPLC-US2009/131468,2009,A1Locationinpatent:Page/Pagecolumn29

[2]CurrentPatentAssignee:ASTRAZENECAPLC-WO2009/64251,2009,A1Locationinpatent:Page/Pagecolumn47

[1]Patent:US2009/131468,2009,A1.Locationinpatent:Page/Pagecolumn34

[2]Patent:WO2009/64251,2009,A1.Locationinpatent:Page/Pagecolumn60-61

[1]Patent:US2009/131468,2009,A1.Locationinpatent:Page/Pagecolumn36

[2]Patent:WO2009/64251,2009,A1.Locationinpatent:Page/Pagecolumn65

[1]Patent:US2009/131468,2009,A1.Locationinpatent:Page/Pagecolumn49

[2]Patent:WO2009/64251,2009,A1.Locationinpatent:Page/Pagecolumn98-99

[3]Patent:WO2010/132016,2010,A1.Locationinpatent:Page/Pagecolumn88

Literature

Title: An excretion balance and pharmacokinetic study of the novel anticancer agent E7070 in cancer patients.

Journal: Anti-cancer drugs 20020901

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
Submit
SDS
Related Products of 27291-96-9
98-10-2

98-10-2
Building Blocks
More >
Tags:27291-96-9 Molecular Formula|27291-96-9 MDL|27291-96-9 SMILES|27291-96-9 benzene-1,2-disulfonamide
Catalog No.: AA00JWBX
27291-96-9,MFCD11106178
27291-96-9 | benzene-1,2-disulfonamide
Pack Size： 1g
Purity： 95+%
2 weeks
$2,052.00 $1,436.00
Pack Size： 2g
Purity： 95+%
2 weeks
$3,062.00 $2,143.00
Pack Size： 5g
Purity： 95+%
2 weeks
$4,476.00 $3,133.00
Pack Size： 10g
Purity： 95+%
2 weeks
$6,533.00 $4,573.00
Pack Size： 25g
Purity： 95+%
2 weeks
$9,729.00 $6,810.00
Pack Size： 50g
Purity： 95+%
2 weeks
$14,394.00 $10,076.00
Pack Size： 100g
Purity： 95+%
2 weeks
$20,419.00 $14,293.00
Quantity
- +
Add to Card
Order Now
bulk Quotation Request
Technical Information
Catalog Number: AA00JWBX
Chemical Name: benzene-1,2-disulfonamide
CAS Number: 27291-96-9
Molecular Formula: C6H8N2O4S2
Molecular Weight: 236.2687
MDL Number: MFCD11106178
SMILES: NS(=O)(=O)c1ccccc1S(=O)(=O)N
Properties
Complexity: 349  
Covalently-Bonded Unit Count: 1  
Defined Atom Stereocenter Count: 0  
Defined Bond Stereocenter Count: 0  
Formal Charge: 0  
Heavy Atom Count: 14  
Hydrogen Bond Acceptor Count: 6  
Hydrogen Bond Donor Count: 2  
Isotope Atom Count: 0  
Rotatable Bond Count: 2  
Undefined Atom Stereocenter Count: 0  
Undefined Bond Stereocenter Count: 0  
XLogP3: -1.3  
Downstream Synthesis Route
59748-90-2    27291-96-9    1154058-75-9 

[1]CurrentPatentAssignee:ASTRAZENECAPLC-US2009/131468,2009,A1Locationinpatent:Page/Pagecolumn27;48-49

[2]CurrentPatentAssignee:ASTRAZENECAPLC-WO2009/64251,2009,A1Locationinpatent:Page/Pagecolumn42

27291-96-9    144059-85-8    1154058-92-0 

[1]CurrentPatentAssignee:ASTRAZENECAPLC-US2009/131468,2009,A1Locationinpatent:Page/Pagecolumn29

[2]CurrentPatentAssignee:ASTRAZENECAPLC-WO2009/64251,2009,A1Locationinpatent:Page/Pagecolumn47

27291-96-9    56518-42-4    1154060-55-5 

[1]Patent:US2009/131468,2009,A1.Locationinpatent:Page/Pagecolumn34

[2]Patent:WO2009/64251,2009,A1.Locationinpatent:Page/Pagecolumn60-61

74346-19-3    27291-96-9    1154060-59-9 

[1]Patent:US2009/131468,2009,A1.Locationinpatent:Page/Pagecolumn36

[2]Patent:WO2009/64251,2009,A1.Locationinpatent:Page/Pagecolumn65

6311-35-9    27291-96-9    1154060-75-9 

[1]Patent:US2009/131468,2009,A1.Locationinpatent:Page/Pagecolumn49

[2]Patent:WO2009/64251,2009,A1.Locationinpatent:Page/Pagecolumn98-99

[3]Patent:WO2010/132016,2010,A1.Locationinpatent:Page/Pagecolumn88

Literature fold

Title: An excretion balance and pharmacokinetic study of the novel anticancer agent E7070 in cancer patients.

Journal: Anti-cancer drugs20020901

Related Products of of 27291-96-9
98-10-2
98-10-2
Building Blocks More >
145914-05-2
145914-05-2
1-chloro-2-(2,2,2-trifluoroethyl)benzene
AA00KS03 | MFCD11226513
1099597-19-9
1099597-19-9
1,4-difluoro-2-(2,2,2-trifluoroethyl)benzene
AA00MYZR | MFCD11226583
2246676-49-1
2246676-49-1
2-methyl-N-[2-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]propanamide
AA00QIF0 | MFCD31916409
41295-58-3
41295-58-3
4-(Chloromethyl)-5,7-dimethyl-2H-chromen-2-one
AA00VRTG | MFCD03664464
1197767-62-6
1197767-62-6
octahydrocyclopenta[b]morpholine hydrochloride
AA00VSVS | MFCD13195915
139665-75-1
139665-75-1
Methyl 6-(chlorosulfonyl)-2-methylbenzoate
AA00VUEJ | MFCD09811225
888022-42-2
888022-42-2
(5-methyl-1,3-oxazol-2-yl)methanol
AA00VVBQ | MFCD11110211
14530-12-2
14530-12-2
1-(1,1-dioxidotetrahydrothien-3-yl)-1-phenylhydrazine
AA0169MN | MFCD01571386
91477-46-2
91477-46-2
3-Bromo-1,5-naphthyridin-4-amine
AA018B63 | MFCD18806391
176240-96-3
176240-96-3
2-(ethanesulfinyl)ethan-1-amine hydrochloride
AA018GTQ | MFCD18483214
Submit
© 2017 AA BLOCKS, INC. All rights reserved.